DiviDrip · IHE

IHE — iShares U.S. Pharmaceutical ETF

IHE is iShares's iShares U.S. Pharmaceutical ETF (Healthcare). Trading at $91.51. Current dividend yield: 1.70%.

Dividend snapshot

Annual dividend rate$1.49
Current yield1.70%
Payment frequencyQuarterly
Next ex-dividend dateJun 17, 2026
Most recent payment dateMar 20, 2026
Last payment amount$0.2845
5-year dividend CAGR16.01%
3-year dividend CAGR6.33%
Expense ratio0.38%
Payout ratio0%
Market cap$946M
ExchangePCX

Recent dividend payments

DateAmount / share
2026-03-17$0.2840
2025-12-16$0.5850
2025-09-16$0.3120
2025-06-16$0.3070
2025-03-18$0.2920
2024-12-17$0.2110
2024-09-25$0.3590
2024-06-11$0.2940

About IHE

The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified.

Track IHE in DiviDrip

Add IHE to your portfolio on DiviDrip to track every buy, DRIP reinvestment, and dividend payment in one place. Free, no credit card, no upsell — built by dividend investors, for dividend investors.

Data refreshed 2026-05-25. Not investment advice. Yields and prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow

Made with Emergent